The need for increasing awareness of osteoporosis in men

Clinical Cornerstone

Volumn 8, Issue SUPPL. 3, 2006, Pages S7-

  Adler, Robert A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; PREDNISONE;

ARTICLE; AWARENESS; BONE DENSITY; BONE MINERAL; CORTICOSTEROID INDUCED OSTEOPOROSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; EVIDENCE BASED MEDICINE; FATALITY; FRAGILITY FRACTURE; GENDER BIAS; HUMAN; OSTEOPOROSIS; PRACTICE GUIDELINE; PRIMARY OSTEOPOROSIS; SCREENING TEST; SECONDARY OSTEOPOROSIS; TREATMENT PLANNING;

EID: 33749573899     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1098-3597(06)80018-9     Document Type: Article

References (52)

1. Kiebzak G.M., Beineart F.A., Perser K., et al. Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med 162 (2002) 2217-2222
2. Feldstein A.C., Nichols G., Orwoll E., et al. The near absence of osteoporosis treatment in older men with fractures. Osteoporos Int 16 (2005) 953-962
3. Johnson S.L., Petkov V.I., Williams M.I., et al. Improving osteoporosis management in patients with fractures. Osteoporos Int 16 (2005) 1079-1085
4. Medicare Coverage (2006). http://www.medicare.gov/Coverage/Home.asp
5. Legrand E., Chappard D., Pascaretti C., et al. Bone mineral density and vertebral fractures in men. Osteoporos Int 10 (1999) 265-270
6. Tuck S.P., Raj N., and Summers G.D. Is distal forearm fracture in men due to osteoporosis?. Osteoporos Int 13 (2002) 630-636
7. Orwoll E.S. Osteoporosis in men. Endocrinol Metab Clin North Am 27 (1998) 349-367
8. Wehren L.E., Hawkes W.G., Orwig D.L., et al. Gender differences in mortality after hip fracture: The role of infection. J Bone Miner Res 18 (2003) 2231-2237
9. Campion J.M., and Maricic M.J. Osteoporosis in men. Am Fam Physician 67 (2003) 1521-1526
10. National Osteoporosis Foundation. Fat Facts (2006). http://www.nof.org/osteoporosis/diseasefacts.htm
11. Riggs B.L., and Melton L.J. Involutional osteoporosis. N Engl J Med 314 (1986) 1676-1686
12. Zerwekh J.E., Sakhaee K., Breslau N.A., et al. Impaired bone formation in male idiopathic osteoporosis: Further reduction in the presence of concomitant hypercalciuria. Osteoporos Int 2 (1992) 128-134
13. Rosen C.J., Kurland E.S., Vereault D., et al. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat of the IGF-I gene: Implications for genetic studies of bone mineral density. J Clin Endocrinol Metab 83 (1998) 2286-2290
14. Van Pottelbergh I., Goemaere S., Zmierczak H., and Kaufman J.M. Perturbed sex steroid status in men with idiopathic osteoporosis and their sons. J Clin Endocrinol Metab 89 (2004) 4949-4953
15. Al-Oanzi Z.H., Tuck S.P., Raj N., et al. Assessment of vitamin D status in male osteoporosis. Clin Chem 52 (2006) 248-254
16. Fitzpatrick L.A. Secondary causes of osteoporosis. Mayo Clin Proc 77 (2002) 453-468
17. Schuit S.C., van der Klift M., Weel A.E., et al. Fracture incidence and association with bone mineral density in elderly men and women: The Rotterdam study. Bone 34 (2004) 195-202
18. Vermeulen A., Kaufman J.M., and Giagulli V.A. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab 81 (1996) 1821-1826
19. Khosla S., Melton L.J., Atkinson E.J., et al. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen. J Clin Endocrinol Metab 83 (1998) 2266-2274
20. Adler R.A. Sex steroids and osteoporosis: The role of estrogens and androgens. Clin Lab Med 20 (2000) 549-558
21. Carani C., Qin K., Simoni M., et al. Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 337 (1997) 91-95
22. International Society for Clinical Densitometry. Updated 2005 Official Positions of the International Society for Clinical Densitometry (2006). http://www.iscd.org/Visitors/positions/official.cfm
23. Van Staa T.P., Leufkens H.G., Abenhaim L., et al. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15 (2000) 993-1000
24. Elliott M.E., Farrah R.M., Binkley N.C., et al. Management of glucocorticoid-induced osteoporosis in male veterans. Ann Pharmacother 34 (2000) 1380-1384
25. Solomon D.H., Katz J.N., Jacobs J.P., et al. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: Rates and predictors of care in an academic rheumatology practice. Arthritis Rheum 46 (2002) 3136-3142
26. Curtis J.R., Westfall A.O., Allison J.J., et al. Longitudinal patterns in the prevention of osteoporosis in glucocorticoidtreated patients. Arthritis Rheum 52 (2005) 2485-2494
27. Adler R.A., and Hochberg M.C. Suggested guidelines for evaluation and treatment of glucocorticoid-induced osteoporosis for the Department of Veterans Affairs. Arch Intern Med 163 (2003) 2619-2624
28. Godschalk M.F., and Downs R.W. Effect of short-term glucocorticoids on serum osteocalcin in healthy young men. J Bone Miner Res 13 (1988) 113-115
29. Siris E.S., Miller P.D., Barrett-Connor E., et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: Results from the National Osteoporosis Risk Assessment. JAMA 286 (2001) 2815-2822
30. Peris P., Pares A., Guanabens N., et al. Bone mass improves in alcoholics after 2 years of abstinence. J Bone Miner Res 9 (1994) 1607-1612
31. Kemppainen T., Kroger H., Janatuinen E., et al. Osteoporosis in adult patients with celiac disease. Bone. Bone 24 (1999) 249-255
32. LeBoff M.S., Kohlmeier L., Hurwitz S., et al. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA 281 (1999) 1505-1511
33. Dawson-Hughes B., Heaney R.P., Holick M.F., et al. Estimates of optimal vitamin D status. Osteoporos Int 16 (2005) 713-716
34. Binkley N., Krueger D., Cowgill C.S., et al. Assay variation confounds the diagnosis of hypovitaminosis D: A call for standardization. J Clin Endocrinol Metab 89 (2004) 3152-3157
35. Tannenbaum C., Clark J., Schwartzman K., et al. Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 87 (2002) 4431-4437
36. Mittan D., Lee S., Miller E., et al. Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs. J Clin Endocrinol Metab 87 (2002) 3656-3661
37. Daniell H.W. Osteoporosis due to androgen deprivation therapy in men with prostate cancer. Urology 58 (2001) 101-107
38. Finkelstein J.S., Klibanski A., Neer R.M., et al. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med 106 (1987) 354-361
39. Leifke E., Korner H.C., Link T.M., et al. Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area, and paraspinal muscle area in hypogonadal men. Eur J Endocrinol 138 (1998) 51-58
40. Reid I.R., Wattie D.J., Evans M.C., and Stapleton J.P. Testosterone therapy in glucocorticoid-treated men. Arch Intern Med 156 (1996) 1173-1177
41. Snyder P.J., Peachey H., Hannoush P., et al. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 84 (1999) 1966-1972
42. Kenny A.M., Prestwood K.M., Gruman C.A., et al. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone level. J Gerontol A Biol Sci Med Sci 56 (2001) M266-M272
43. Amory J.K., Watts N.B., Easley K.A., et al. Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab 89 (2004) 503-510
44. Rhoden E.L., and Morgentaler A. Risks of testosteronereplacement therapy and recommendations for monitoring. N Engl J Med 350 (2004) 482-492
45. Brunader R., and Shelton D.K. Radiologic bone assessment in the evaluation of osteoporosis. Am Fam Physician 65 (2002) 1357-1364
46. Published October 14, 2004. Available at:. US Department of Health & Human Services. Accessed April 17. Bone Health and Osteoporosis: A Report of the Surgeon General (2006). http://www.surgeongeneral.gov/library/bonehealth/chapter8.html
47. Available at:. Anderson M., and Delmas P.D. Accessed April 17. Osteoporosis: An Underdiagnosed and Undertreated Public Health Issue (2006). http://www.osteofound.org/publications/pdf/kargergazette.pdf
48. In: Shiel W.C. (Ed). Bone Density Scan (2006). http://www.medicinenet.com/script/main/art.asp?articlekey=12114&pf=3&pag e=1
49. Wilkins C.H., and Birge S.J. Prevention of osteoporotic fractures in the elderly. Am J Med 118 (2005) 1190-1195
50. Kanis J.A., Borgstrom F., De Laet C., et al. Assessment of fracture risk. Osteoporos Int 16 (2005) 581-589
51. Adler R.A., Tran M.T., and Petkov V.I. Performance of the osteoporosis self-assessment tool for osteoporosis in American men. Mayo Clin Proc 78 (2003) 723-727
52. Abstract M113. Adler R.A., Petkov V.I., Via P.S., and Williams M.I. Screening men 70 years and older for osteoporosis: Are we missing osteoporosis in younger men?. J Bone Miner Res 19 Suppl 1 (2004) S369